Search research articles
Contact Us
Filters
Showing results (11-20 of 101) with videos related to
Page
of 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 31, 2003
Use of total lymphocyte count for monitoring response to antiretroviral therapy
Tanya Schreibman, Gerald Friedland
Expert Opinion on Pharmacotherapy
|
May 23, 2007
Managing multiple and extensively drug-resistant tuberculosis and HIV
Nesri Padayatchi, Gerald Friedland
Annual Review of Medicine
|
July 28, 2009
Extensively drug-resistant tuberculosis: a new face to an old pathogen
Sheela Shenoi, Gerald Friedland
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 17, 2020
Preventing COVID-19 Collateral Damage
James Shepherd, Gerald Friedland
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 15, 2011
Integration of buprenorphine for substance-abuse treatment by HIV care providers
Gerald Friedland, David Vlahov
The Journal of Infectious Diseases
|
August 30, 2007
Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies
Gerald Friedland, Anthony Harries, David Coetzee
Expert Opinion on Drug Metabolism & Toxicology
|
May 4, 2016
Drug interactions between buprenorphine, methadone and hepatitis C therapeutics
Onyema Ogbuagu, Gerald Friedland, R Douglas Bruce
The Journal of Infectious Diseases
|
August 30, 2007
Tuberculosis and HIV coinfection: current state of knowledge and research priorities
Gerald Friedland, Gavin J Churchyard, Edward Nardell
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
July 15, 2004
HAART for hospital health care workers--an innovative programme
Kerry Uebel, Gerald Friedland, Robert Pawinski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 20, 2010
Transmission of drug-susceptible and drug-resistant tuberculosis and the critical importance of airborne infection control in the era of HIV infection and highly active antiretroviral therapy rollouts
Sheela V Shenoi, A Roderick Escombe, Gerald Friedland
Page
of 11
Search research articles
Search
Showing results (11-20 of 101) with videos related to
Sort By:
Page
of 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 31, 2003
Use of total lymphocyte count for monitoring response to antiretroviral therapy
Tanya Schreibman, Gerald Friedland
Expert Opinion on Pharmacotherapy
|
May 23, 2007
Managing multiple and extensively drug-resistant tuberculosis and HIV
Nesri Padayatchi, Gerald Friedland
Annual Review of Medicine
|
July 28, 2009
Extensively drug-resistant tuberculosis: a new face to an old pathogen
Sheela Shenoi, Gerald Friedland
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 17, 2020
Preventing COVID-19 Collateral Damage
James Shepherd, Gerald Friedland
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 15, 2011
Integration of buprenorphine for substance-abuse treatment by HIV care providers
Gerald Friedland, David Vlahov
The Journal of Infectious Diseases
|
August 30, 2007
Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies
Gerald Friedland, Anthony Harries, David Coetzee
Expert Opinion on Drug Metabolism & Toxicology
|
May 4, 2016
Drug interactions between buprenorphine, methadone and hepatitis C therapeutics
Onyema Ogbuagu, Gerald Friedland, R Douglas Bruce
The Journal of Infectious Diseases
|
August 30, 2007
Tuberculosis and HIV coinfection: current state of knowledge and research priorities
Gerald Friedland, Gavin J Churchyard, Edward Nardell
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
July 15, 2004
HAART for hospital health care workers--an innovative programme
Kerry Uebel, Gerald Friedland, Robert Pawinski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 20, 2010
Transmission of drug-susceptible and drug-resistant tuberculosis and the critical importance of airborne infection control in the era of HIV infection and highly active antiretroviral therapy rollouts
Sheela V Shenoi, A Roderick Escombe, Gerald Friedland
Page
of 11